Personalized Medicine and the Treatment of Hypertension
- PMID: 30747306
- PMCID: PMC6594382
- DOI: 10.1007/s11906-019-0921-3
Personalized Medicine and the Treatment of Hypertension
Abstract
Purpose of review: The purpose of this review is to discuss the implications of personalized medicine for the treatment of hypertension, including resistant hypertension.
Recent findings: We suggest a framework for the personalized treatment of hypertension based on the concept of a trade-off between simplicity and personalization. This framework is based on treatment strategies classified as low, medium, or high information burden personalization approaches. The extent to which a higher information burden is justified depends on the clinical scenario, particularly the ease with which the blood pressure can be controlled. A one-size-fits-many treatment strategy for hypertension is efficacious for most people; however, a more personalized approach could be useful in patients with subtypes of hypertension that do not respond as expected to treatment. Clinicians seeing patients with unusual hypertension phenotypes should be familiar with emerging trends in personalized treatment of hypertension.
Keywords: Blood pressure; Hypertension; Personalized medicine; Population health; Primary aldosteronism; Resistant hypertension.
Figures
References
-
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388(10053):1659–724. doi: 10.1016/s0140-6736(16)31679-8. - DOI - PMC - PubMed
-
- Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet 2018;392(10159):2052–90. doi: 10.1016/s0140-6736(18)31694-5. - DOI - PMC - PubMed
-
- Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018;71(6):1269–324. doi: 10.1161/hyp.0000000000000066. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
